RENO, Nev.–(BUSINESS WIRE)–#blockchain–Crucial Data Solutions (CDS), a provider of innovative technologies to advance clinical research, announced today that industry veteran Jim Bob Ward has joined the company as Chief Strategy Officer. In this newly created role, Ward will continue to refine and execute on CDS’ strategic vision for its eClinical platform, TrialKit, by applying his … [Read more…]
DSMC finds no safety concerns, allows use of highest dose for continued administration. Interim analysis of the trial expected in next month Company opens Spanish subsidiary to lead EU clinical trials ATLANTA–(BUSINESS WIRE)–Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “2022 U.S CT Market Outlook Report” report has been added to ResearchAndMarkets.com’s offering. This 2022 CT Market Outlook Report summarizes the results of the Medical Information Division’s 2022 survey of U.S. hospitals and Independent Imaging Centers that perform CT procedures using fixed CT scanners and provide a summary of the CT medical imaging … [Read more…]
ST. PETERSBURG, Fla.–(BUSINESS WIRE)–PathO3Gen Solutions multi-patented UVZone® shoe sanitizing technology is proven to eliminate Candida auris up to 99.9993% in 10 seconds. The Centers of Disease Control (CDC) continues reporting on the Candida auris outbreak, a potentially deadly fungus which causes severe illness for long-term care and long-term hospitalized patients, such as those in nursing … [Read more…]
SEOUL, South Korea–(BUSINESS WIRE)–A clinical-staged proprietary platform technology biotech company Genexine (KQ 095700, CEO Neil Warma) and its Asian regional partner, KG Bio unveiled the interim results of phase 3 clinical trial of GX-E4 (Efepoetin alfa), a candidate for CKD (Chronic Kidney Disease) induced anemia. Its non-inferiority results compared to Mircera (Methoxy Polyethylene Glycol-epoetin beta) … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “2022 U.S Nuclear Medicine Market Outlook Report” report has been added to ResearchAndMarkets.com’s offering. The 2022 Nuclear Medicine Market Outlook examines nuclear medicine procedure volumes, purchase plans, and buying criteria for future nuclear medicine purchases. Learn how NM administrators feel about their department’s future outlook and how they prioritize their goals in light … [Read more…]
Implantable shock absorber (ISA) relieves pain and improves function in people ineligible for, or unwilling to undergo, joint replacement MISHA Knee System is implanted during an outpatient procedure; it’s the first and only device of its kind for people with symptomatic knee OA More than 32 million people in the United States are affected by … [Read more…]
BRISBANE, Calif.–(BUSINESS WIRE)–Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, announced today that it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that based on the Company’s April 7, 2023 filing of its Form 10-K for the period … [Read more…]
EVERETT, Wash.–(BUSINESS WIRE)–Compass Health is pleased to announce its sixth-annual Building Communities of Hope Gala raised $225,000 in support of the organization’s child, youth and family behavioral health services – more than doubling the amount raised over the past two years. The event, held on March 25, at the Tulalip Resort Casino, also attracted its … [Read more…]
NEW YORK–(BUSINESS WIRE)–Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced the launch of Mia Femtech™ (“Mia®”) in Japan, marking the beginning of a new era in breast aesthetics. “In 2013, we recognized that traditional breast augmentation was … [Read more…]
